Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort ...

In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies ​said, in an effort ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

A sharp rise in cyberattacks is disrupting food and beverage supply chains, with ransomware targeting retailers, processors ...

Drug-induced fever can complicate antibiotic treatment and lead to unnecessary testing when cultures are negative, and ...

A petroleum and cooking gas filling station located along the Bukuru Expressway, popularly known as Chill Cherry, was on ...

Niktimvo™ (axatilimab-csfr) 4Q25 and full year 2025 net revenue, respectively; Syndax will report its share of the Niktimvo net profit when it reports full year 2025 results – – Ended 2025 with ...

VolitionRx Limited ("Volition"), a multi-national epigenetics company, announces the sponsorship of an industry symposium at the world's leading veterinary education conference,  Veterinary Meeting ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

Syndax Pharmaceuticals ( (SNDX) ) has shared an announcement.